Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| C-rad Ab | LSE:0R44 | London | Ordinary Share | SE0002016352 | C-RAD ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.15 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electromedical Apparatus | 425.44M | 35.53M | 1.0798 | 31.63 | 1.12B |
From Dec 2019 to Dec 2024
STOCKHOLM, April 23, 2021 /PRNewswire/ -- Invitation to join the presentation of C-RAD's first quarter 2021. CEO Tim Thurn will also give his Annual General Meeting speech at this event. The AGM is held on May 7 but without any presence from shareholders or other parties, as communicated previously in the call for the AGM.
Date: Thursday May 7, 2021 / kl. 11:00 CET
Venue: Online Presentation
Topic: C-RAD Interim Report Q1 2021 / AGM speech
Procedure:
Please register online through the website:
https://us06web.zoom.us/webinar/register/WN_xs_0KzMGT7qEExqblSLzmw
After the registration, you will receive a confirmation via email.
A recording of the presentation will be made accessible on the C-RAD website after the presentation.
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/c-rad/r/c-rad-web-presentation-interim-report-q1-2021-and-agm-speech,c3329865
The following files are available for download:
https://mb.cision.com/Main/13008/3329865/1404732.pdf | PR 210423 Invitation to webcast Interim Report Q1 2021 |
View original content:http://www.prnewswire.com/news-releases/c-rad-web-presentation-interim-report-q1-2021-and-agm-speech-301275733.html
SOURCE C-RAD
Copyright 2021 PR Newswire
1 Year C-rad Ab Chart |
1 Month C-rad Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
